Skip to content

Nursing guidelines on management of hypernatremia and diabetes insipidus.

A randomized control trial to assess the effectiveness of nurse initiated guidelines on management of hypernatremia and diabetes DI among postoperative patients of sellar/ suprasellar tumour surgery.

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2018/07/015127
Enrollment
50
Registered
2018-07-31
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: null- Post operative patient with sellar and suprasellar tumour surgery

Interventions

Intervention1: nurse initiated guidelines: nurse initiated guidelines for the management of diabetes inscipidus and hypernatremia Control Intervention1: Routine management: two group control and exper

Sponsors

Hemlata
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. All postoperative patients with sellar and suprasellar tumour admitted in neurosurgical units of Nehru Hospital, PGIMER, Chandigarh during July-September 2018. 2. Participant who will be willing to participate in the study.

Exclusion criteria

Exclusion criteria: 1. Patient having known case of: -Diabetes insipidus -Diseases causing fluid electrolyte imbalance like CRF/CKD/Renal disorder 2. The post operative patient with sellar and suprasellar tumour who are not willing to participate.

Design outcomes

Primary

MeasureTime frame
Hypernatremia 1. Number of episodes 2. Severity Diabetes insipidus 1. Number of episodes 2. Clinical manifestations of DI Timepoint: 2 months

Secondary

MeasureTime frame
Secondary outcome variables -Duration of hospital stay -Number of readmission within a month. Dehydration/ dry mouth, Polydipsia, Fatigue, Irritability/ restlessness Polyuria/ oliguria Altered level of consciousness, Tachycardia Timepoint: 2 months

Countries

India

Contacts

Public ContactHemlata

Postgraduate Institute of medical Education and Research, chandigarh

manjuseban@gmail.com9855151528

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 15, 2026